Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REPLACE: Basiliximab in CNI-intolerant kidney transplant recipients
NCT00284947Phase 4Completed
- Sponsor
- Novartis
- Start
- Jan 2006
- Primary completion
- Dec 2008
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of basiliximab in kidney transplant rejection, sponsored by Novartis. Started Jan 2006; status: completed.
02
Drugs
basiliximab
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT00284947.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00284947.